Hypoxia and angiogenesis in rheumatoid arthritis

被引:161
作者
Taylor, PC [1 ]
Sivakumar, B [1 ]
机构
[1] Univ London Imperial Coll Sci & Technol, Fac Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England
关键词
angiogenesis; hypoxia; hypoxia-inducible-factor rheumatoid arthritis; vascular endothelial growth factor;
D O I
10.1097/01.bor.0000155361.83990.5b
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Angiogenesis is a prominent feature of rheumatoid synovitis, Although new blood vessels deliver oxygen to the augmented inflammatory cell mass, the neovascular network is dysfunctional and fails to restore tissue oxygen homeostasis, so that the rheumatoid joint remains a markedly hypoxic environment. The purpose of this review is to discuss the role of hypoxia and angiogenesis in the pathogenesis of rheumatoid arthritis. Recent findings Vascular pathologic change, in the form of angiogenesis, is important in the perpetuation of rheumatoid arthritis and, in the form of endothelial dysfunction, contributes to associated cardiovascular comorbidity. Recent data suggest that tumor necrosis factor-alpha blockade may modify the vascular pathologic changes in rheumatoid arthritis. Angiogenesis is a prominent feature of rheumatoid synovitis. Emerging evidence based on ultrasonographic vascular imaging and angiogenic biomarkers implicates angiogenesis in the active phase of erosive disease. Many factors contribute to the profoundly hypoxic environment that can arise within the joint affected by rheumatoid arthritis. At a cellular level, hypoxia is detected by a mechanism that regulates cytoplasmic concentrations of hypoxia-inducible factor-1 alpha. After translocation to the nucleus, hypoxia-inducible factor-1 alpha binds its partner hypoxia-inducible factor-1 beta to form a heterodimeric, functional transcription factor, hypoxia-inducible factor-1, which activates a gene program associated with angiogenesis, glycolysis, and adaptation to pH. Summary Despite the luxuriant vasculature associated with rheumatoid arthritis synovitis, the joint affected by rheumatoid arthritis is hypoxic. Repetitive cycles of hypoxia and reoxygenation together with oxidants produced by phagocytic cells promote chronic oxidative stress within the microenvironment of the affected joint, leading to the generation of reactive oxygen species with the potential to contribute to tissue damage.
引用
收藏
页码:293 / 298
页数:6
相关论文
共 75 条
[1]   The vascular endothelial growth factor family; proteins which guide the development of the vasculature [J].
Achen, MG ;
Stacker, SA .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 1998, 79 (05) :255-265
[2]  
Ballara S, 2001, ARTHRITIS RHEUM, V44, P2055, DOI 10.1002/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO
[3]  
2-2
[4]   Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis [J].
Bergholm, R ;
Leirisalo-Repo, M ;
Vehkavaara, S ;
Mäkimattila, S ;
Taskinen, MR ;
Yki-Järvinen, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (10) :1637-1641
[5]  
Berse B, 1999, CLIN EXP IMMUNOL, V115, P176
[6]   Xanthine oxidase: four roles for the enzyme in rheumatoid pathology [J].
Blake, DR ;
Stevens, CR ;
Sahinoglu, T ;
Ellis, G ;
Gaffney, K ;
Edmonds, S ;
Benboubetra, M ;
Harrison, R ;
Jawed, S ;
Kanczler, J ;
Millar, TM ;
Winyard, PG ;
Zhang, Z .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (03) :812-816
[7]  
Bottomley MJ, 1999, CLIN EXP IMMUNOL, V117, P171
[8]  
BROWN LF, 1997, EXS, V79, P233, DOI DOI 10.1007/978-3-0348-9006-9_10
[9]   Antiangiogenic effects of anti-tumor necrosis factor a therapy with infliximab in psoriatic arthritis [J].
Cañete, JD ;
Pablos, JL ;
Sanmartí, R ;
Mallofré, C ;
Marsal, S ;
Maymó, J ;
Gratacós, J ;
Mezquita, J ;
Mezquita, C ;
Cid, MC .
ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1636-1641
[10]   CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor [J].
Cho, CS ;
Cho, ML ;
Min, SY ;
Kim, WU ;
Min, DJ ;
Lee, SS ;
Park, SH ;
Choe, J ;
Kim, HY .
JOURNAL OF IMMUNOLOGY, 2000, 164 (10) :5055-5061